Skip to main content
. Author manuscript; available in PMC: 2018 Sep 23.
Published in final edited form as: Am J Prev Med. 2018 Mar 17;54(5):e91–e98. doi: 10.1016/j.amepre.2018.02.009

Figure 1.

Figure 1.

Final mediational model of the relationship between concern about prescription drug misuse and abuse and intention to use the California’s PDMP.

Parameters represent unstandardized coefficients; presence of multiple path coefficients represents physicians and pharmacists, respectively. Covariance among exogenous variables and mediators were omitted for clarity. CS = controlled substances. Solid black lines indicate statistically significant paths and dashed black lines indicate non-significant paths among substantive pathways. Solid gray lines indicate paths for control variables.

*** p <.001